Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel method for synthesizing prulifloxacin

A compound, a methyl technology, is applied in the new field of synthesis of prulifloxacin, which can solve the problems of product yield decline, difficulty in purification, and high difficulty, so as to reduce the generation of impurities, simplify the post-processing steps, and improve the utilization rate of raw materials Improved effect

Inactive Publication Date: 2009-04-29
湖南华纳大药厂手性药物有限公司
View PDF1 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] Disadvantages: The first route has long reaction steps, and special reagent EtOMgCH(CO 2 Et) 2 ; At the same time, the route is also more polluting to the environment
[0011] Disadvantages: The reaction process of the second route requires a -78°C ultra-low temperature reaction, which is extremely unfavorable for scientific research and industrial production, and should not be used
[0015] Disadvantages: Although the third route has relatively short reaction steps, it must use the special reagent N-carboxylate triethylamine salt, which is difficult to meet large-scale production
[0018] Disadvantages: The fourth route has no special reaction during the synthesis process, but because the toxic reagent chloromethyl methyl ether is used in the reaction, and 1,1-dibromoethane is expensive; at the same time, the reaction yield of this route is low, If this route is chosen, the cost is too high
[0023] (1) bromide is unstable, and it is difficult to purify in large-scale production;
[0024] (2) Impurities such as I and II are inevitably produced due to excessive alkylation (as shown in the diagram below), and the process of removing these impurities is difficult, and at the same time, the product yield is greatly reduced;
[0026] In addition, the yields of the above synthetic methods are not high. Although the fifth synthetic route has great application value, it has very obvious defects, and the difficulty of industrialized large-scale production is very large. The present invention is based on this, and after screening and research , found better process conditions and solved the existing problems in the synthesis of prulifloxacin

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel method for synthesizing prulifloxacin
  • Novel method for synthesizing prulifloxacin
  • Novel method for synthesizing prulifloxacin

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0058] 1, the preparation of formula (IV) compound:

[0059] In a 500ml three-necked bottle, N 2 Add 5.3g of magnesium bars, 100ml of anhydrous THF and 5mg of iodine under protection, then slowly add 35.6g of the THF solution of the compound of formula (II) dropwise under heating and reflux, then reflux and stir for 2 hours, and quickly add 9.8g of the formula ( III) acetaldehyde, continue to reflux for 8 hours, heat and concentrate to recover THF, slowly add ice water and ethyl acetate to the residue under cooling and stirring, filter with suction, extract the filtrate, wash the organic phase with water, anhydrous Na 2 SO 4 Dry overnight, concentrate, dissolve the residue in acetone, add Jones reagent (Jones) dropwise while maintaining the reaction temperature at 20°C, continue the reaction for 2 hours, filter with suction, concentrate the filtrate, dissolve the residue in water, extract with chloroform, wash with water, anhydrous Na 2 SO 4 After drying and concentrating, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
Login to View More

Abstract

The invention relates to a method for synthesizing prulifloxacin of formula (I) with a chemical name of 6-fluoro-1-methyl-7-[4-(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl-1-piperazinyl]-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylicacid. The method for synthesizing prulifloxacin is suitable for industrial production and has the advantages of simple process, high purity and high yield.

Description

technical field [0001] The present invention generally relates to a novel synthetic method of quinolone antibacterial drugs, more specifically, the present invention relates to a method for synthesizing the following formula (I) prulifloxacin (prulifloxacin) [chemical name: 6-fluoro-1-methyl- 7-[4-(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl-1-piperazinyl]-4-oxo-4H-[1, 3] A new method for thiazetidin[3,2-a]quinoline-3-carboxylic acid]. [0002] Background technique [0003] Since the advent of quinolone antibacterial drugs in the 1960s, they have become a large class of commonly used anti-infection drugs widely used in clinical practice. Due to the advantages of broad antibacterial spectrum, strong antibacterial power, simple structure, convenient administration, no cross-resistance with other commonly used antibacterial drugs, and high curative effect and price ratio, this kind of drugs has attracted more and more attention and has become the field of research and development...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D513/04A61P31/04
Inventor 黄本东陈爽段新方
Owner 湖南华纳大药厂手性药物有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products